Routine Cerebral Embolic Protection Did Not Reduce Incidence of Peri-procedural Stroke in TAVI: BHF PROTECT-TAVI
Key Points: Stroke remains one of the most feared complications of transcatheter aortic valve implantation (TAVI), prompting interest in cerebral embolic protection... Read more.
TAVR with Trilogy System Safe and Effective for Aortic Regurgitation: Updated Results from ALIGN-AR
Key Points: Transcatheter aortic valve replacement for aortic valve disease has largely focused on those with aortic stenosis. In pure, native-valve aortic regurgitation,... Read more.
Bentracimab Significantly Restored Platelet Function in Patients Taking Ticagrelor and Undergoing Urgent Surgery
Key Points: A major limitation of antithrombotic therapy is the risk of bleeding if a patient requires urgent surgical or invasive procedures as well as the risk... Read more.
Reconditioned Pacemakers Non-Inferior To New Pacemakers in Low- and Middle-Income Countries: Preliminary Results from My Heart Your Heart Trial
Key Points: Many patients in low- and middle-Income countries are unable to obtain new pacemaker devices. It is unknown if reconditioned pacemakers are as effective... Read more.
Linear Ablation Combined with EIVOM Provides Additional Benefit in Rhythm Outcomes for Persistent AF Ablation: PROMPT-AF Trial
Key Points: It is unknown if linear ablation with ethanol infusion of the vein of Marshall (EIVOM) in addition to pulmonary vein isolation (PVI) improves outcomes... Read more.
Metformin and Aggressive Lifestyle Modifications Reduce AF Fibrillation Symptoms but Not Burden: Results From the TRIM-AF Trial
Key Points: Despite prior data suggesting decrease in metabolic stress may reduce atrial fibrillation (AF) progression, the effects of aggressive lifestyle and risk... Read more.
Edoxaban Comparable to Warfarin After Surgical Bioprosthetic Valves Implantation: ENBALV Trial
Key Points: In patients after surgical bioprosthetic valves, it remains unclear if edoxaban is safe and effective in preventing valve complicates early after surgery.... Read more.
Rivaroxaban Did Not Reduce Cognitive Decline and Stroke/TIA in Young AF Patients: BRAIN-AF Trial
Key Points: In patients with atrial fibrillation, it remains unclear if anticoagulation therapy reduces the incidence of neurocognitive impairment In this randomized... Read more.